tenk.fyi

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXTNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$6.1M

69.5% YoY

EPS

$-1.26

20.8% YoY

Cash

-

FY 2025 · As of 2025-12-31